BD 232087 - Disk Susceptibility Sensi-Disc Tigecycline 15mcg Accurate Antimicrobial Sensitivity Testing for Multidrug-Resistant Organisms, EA

BD 232087 - Disk Susceptibility Sensi-Disc Tigecycline 15mcg Accurate Antimicrobial Sensitivity Testing for Multidrug-Resistant Organisms, EA

The BD 232087 Disk Susceptibility Sensi-Disc Tigecycline 15mcg is a precision-manufactured antimicrobial susceptibility testing (AST) reagent designed to determine bacterial sensitivity to tigecyclinea broad-spectrum glycylcycline antibiotic effective against Gram-positive, Gram-negative, and multidrug-resistant (MDR) bacteria. Each sterile paper disk is impregnated with 15 micrograms of tigecycline, ensuring standardized diffusion and accurate inhibition zone measurement in disk diffusion assays such as the Kirby-Bauer test. Produced under BDs rigorous quality controls, these disks provide reliable and reproducible results that help laboratories and clinicians make informed antimicrobial therapy decisions.

Key Benefits

The BD 232087 Tigecycline Sensi-Disc offers superior precision, reliability, and consistency in susceptibility testing. Its standardized 15mcg antibiotic concentration ensures uniform diffusion and precise antimicrobial gradient formation. The sterile, single-use format minimizes contamination risk, supporting aseptic workflow and accurate results. By enabling rapid, dependable detection of tigecycline resistance or susceptibility, this reagent plays a key role in guiding treatment strategies for infections caused by multidrug-resistant pathogens such as Enterobacteriaceae, Acinetobacter baumannii, and Staphylococcus aureus.

Compatibility and Applications

The BD 232087 Sensi-Disc Tigecycline 15mcg is compatible with standard Mueller-Hinton agar and meets testing protocols defined by the CLSI (Clinical and Laboratory Standards Institute) and EUCAST (European Committee on Antimicrobial Susceptibility Testing). It is used in the disk diffusion method for assessing susceptibility in a wide variety of clinical isolates, including both Gram-positive and Gram-negative bacteria. Common applications include routine diagnostic testing, antibiotic resistance surveillance, and antimicrobial research in hospital, pharmaceutical, and reference laboratories.

Usage Guidelines

Follow standardized susceptibility testing procedures according to CLSI or EUCAST guidelines. Prepare a bacterial suspension equivalent to a 0.5 McFarland standard and evenly inoculate the surface of Mueller-Hinton agar. Apply the BD 232087 Tigecycline 15mcg disk aseptically using sterile forceps or a disk dispenser. Incubate the plates at 3537C for 1620 hours in ambient air. After incubation, measure the inhibition zone diameter in millimeters and interpret the results using current interpretive criteria. Store disks at 28C in a dry, dark location and allow them to reach room temperature before use to avoid condensation.

Certifications, Safety Standards, and Regulatory Approvals

The BD 232087 Tigecycline Sensi-Disc is produced under ISO 9001 and ISO 13485 certified quality management systems. It complies with FDA and CE requirements for in vitro diagnostic (IVD) medical devices. Each batch undergoes rigorous testing for potency, diffusion uniformity, and sterility in alignment with CLSI M100 standards. BDs strict quality control process ensures consistency and reproducibility for reliable antimicrobial susceptibility results.

Comparison with Competitor Products

Compared to competitor antibiotic testing disks, BDs Sensi-Discs stand out for their superior precision, lot-to-lot consistency, and long-term stability. Many competitor disks exhibit variability in antibiotic content or diffusion rate, leading to inconsistent inhibition zones. BDs advanced impregnation process guarantees exact drug dosage and uniform distribution across every disk. The packaging system maintains disk potency and protects against humidity, ensuring dependable performance throughout the products shelf life.

Typical User Profile and Application Scenarios

The BD 232087 Tigecycline 15mcg Sensi-Disc is designed for use by microbiologists, clinical laboratory technologists, and infection control professionals in hospitals, diagnostic centers, pharmaceutical research facilities, and public health laboratories. It is particularly valuable for identifying multidrug-resistant strains of Enterococcus, Klebsiella, Acinetobacter, and Staphylococcus species, helping clinicians determine effective therapeutic regimens against complex infections.

Best Practices for Use and Maintenance

Handle disks aseptically with sterile forceps to prevent contamination. Store disks in sealed containers with desiccants to protect against moisture. Avoid temperature fluctuations and excessive light exposure. Regularly verify test accuracy using quality control strains such as Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213. Do not use disks beyond their expiration date, as reduced antibiotic activity may lead to inaccurate results. Dispose of used disks and plates as biohazardous waste according to institutional guidelines.

Regulatory and Safety Information

The BD 232087 Tigecycline 15mcg Sensi-Disc is intended for in vitro diagnostic use only by trained laboratory professionals. While the disks are non-toxic, cultures tested with them may contain pathogenic bacteria and should be handled according to biosafety level 2 (BSL-2) practices. Always wear gloves, lab coats, and eye protection when performing susceptibility testing. Dispose of all contaminated materials in compliance with local and institutional biosafety regulations.

How to Order

To order the BD 232087 Disk Susceptibility Sensi-Disc Tigecycline 15mcg, add the product to your cart and complete your purchase securely through CIA Medicals online ordering system. For bulk or institutional orders, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page. Our support team can provide detailed product information, pricing, and documentation to support your laboratorys antimicrobial testing needs.